Stay updated

Press Releases

This is the place where you can find the most recent public press releases from NuLife Sciences.

This study, focused on kidney patients, reveals that the patented formulation of Endocalyx Pro restores the endothelial glycocalyx when exposed to toxic hemodialysis plasma.
March 21, 2023
For the first time, we can now determine quantitative microvascular scores that correlate very well with accepted clinical parameters in individual sepsis patients for a wide range of clinical severitie.
September 14, 2022
The study, using GlycoCheck endothelial glycocalyx testing technology, measured glycocalyx barrier properties in psoriasis, as well as their correlation with coronary microcirculatory function.
September 7, 2022
GlycoCheck, a medical testing device, was used in a new peer-reviewed study published by the American Journal of Physiology.
September 1, 2022
NuLife Sciences, based in Chattanooga, TN, announces that a new peer-reviewed study using GlycoCheck™ has been published .
August 16, 2022
CEO, William Resides announces that as of July 1st, 2022, BioRegenx has moved from due diligence to a binding letter of intent to merge with a public company. These steps also include drafting the definitive agreement for the final merger.
July 22, 2022
The benefits of PEMF (Pulsed Electro-Magnetic Field) therapy is no secret among wellness experts with a four-year study conducted by NASA to understand its benefits and effects on human wellbeing. NuLife Sciences introduces a portable and affordable PEMF therapy device called the Sedona Face.
December 11, 2020
VNox+ was carefully crafted for NuLife Sciences to support the production of nitric oxide in the body. The discovery that nitric oxide (NO) is a signaling molecule in the cardiovascular system whereby dilating blood vessels was awarded a Nobel Prize in Physiology or Medicine in 1998.
October 28, 2020